JP2023517532A5 - - Google Patents

Info

Publication number
JP2023517532A5
JP2023517532A5 JP2022552858A JP2022552858A JP2023517532A5 JP 2023517532 A5 JP2023517532 A5 JP 2023517532A5 JP 2022552858 A JP2022552858 A JP 2022552858A JP 2022552858 A JP2022552858 A JP 2022552858A JP 2023517532 A5 JP2023517532 A5 JP 2023517532A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
epinephrine
type
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022552858A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023517532A (ja
Filing date
Publication date
Priority claimed from US17/135,528 external-priority patent/US11400045B2/en
Application filed filed Critical
Publication of JP2023517532A publication Critical patent/JP2023517532A/ja
Publication of JP2023517532A5 publication Critical patent/JP2023517532A5/ja
Priority to JP2026028936A priority Critical patent/JP2026094260A/ja
Pending legal-status Critical Current

Links

JP2022552858A 2020-03-16 2021-03-16 粉末化された鼻腔内エピネフリンによる治療 Pending JP2023517532A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026028936A JP2026094260A (ja) 2020-03-16 2026-02-25 粉末化された鼻腔内エピネフリンによる治療

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062989913P 2020-03-16 2020-03-16
US62/989,913 2020-03-16
US17/135,528 US11400045B2 (en) 2020-03-16 2020-12-28 Treatment with powdered intranasal epinephrine
US17/135,528 2020-12-28
PCT/IL2021/050288 WO2021186437A1 (en) 2020-03-16 2021-03-16 Treatment with powdered intranasal epinephrine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026028936A Division JP2026094260A (ja) 2020-03-16 2026-02-25 粉末化された鼻腔内エピネフリンによる治療

Publications (2)

Publication Number Publication Date
JP2023517532A JP2023517532A (ja) 2023-04-26
JP2023517532A5 true JP2023517532A5 (cg-RX-API-DMAC7.html) 2024-03-27

Family

ID=77664091

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022552858A Pending JP2023517532A (ja) 2020-03-16 2021-03-16 粉末化された鼻腔内エピネフリンによる治療
JP2026028936A Pending JP2026094260A (ja) 2020-03-16 2026-02-25 粉末化された鼻腔内エピネフリンによる治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026028936A Pending JP2026094260A (ja) 2020-03-16 2026-02-25 粉末化された鼻腔内エピネフリンによる治療

Country Status (13)

Country Link
US (2) US11400045B2 (cg-RX-API-DMAC7.html)
EP (1) EP4121005A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023517532A (cg-RX-API-DMAC7.html)
KR (1) KR20220154709A (cg-RX-API-DMAC7.html)
CN (1) CN115279340A (cg-RX-API-DMAC7.html)
AR (1) AR121593A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021239084A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022018440A2 (cg-RX-API-DMAC7.html)
CA (1) CA3175130A1 (cg-RX-API-DMAC7.html)
IL (1) IL296268A (cg-RX-API-DMAC7.html)
MX (1) MX2022011464A (cg-RX-API-DMAC7.html)
TW (1) TW202200119A (cg-RX-API-DMAC7.html)
WO (1) WO2021186437A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11400045B2 (en) * 2020-03-16 2022-08-02 Nasus Pharma Ltd. Treatment with powdered intranasal epinephrine
CN121265577A (zh) 2020-05-18 2026-01-06 奥瑞克索股份公司 用于药物递送的药物组合物
US12414916B2 (en) 2021-06-10 2025-09-16 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
US11617716B2 (en) 2021-06-10 2023-04-04 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
US12661315B2 (en) 2021-06-10 2026-06-23 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
TW202333658A (zh) 2021-11-25 2023-09-01 瑞典商奥瑞克索股份公司 包含腎上腺素之新穎醫藥組合物
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
AU2023322235A1 (en) * 2022-08-11 2025-03-13 De Motu Cordis Pty Ltd Inhalable epinephrine formulation
US12029709B2 (en) 2022-08-11 2024-07-09 De Motu Cordis Pty Ltd Inhalable epinephrine formulation
KR20260016535A (ko) * 2023-05-31 2026-02-03 오렉쏘 에이비 아드레날린 수용체 조절제를 포함하는 분무 건조 조성물
US20260108465A1 (en) 2024-10-21 2026-04-23 Belhaven BioPharma Inc. Compositions, devices, and methods for intranasal delivery of dry powder epinephrine

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940006601A (ko) 1992-09-12 1994-04-25 야나가와 히로미 생리활성 펩티드 조성물
US6017963A (en) 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
ATE289825T1 (de) 1999-04-21 2005-03-15 1355540 Ontario Inc Methacoline oder histamine formulierungen zur feststellung von asthma
GB2367756B (en) 2000-10-12 2003-01-08 Bespak Plc Dispensing apparatus
GB2380410B (en) 2001-10-05 2003-11-19 Alchemy Healthcare Ltd Apparatus for the nasal or oral delivery of a medicament
GB2384190A (en) 2002-01-22 2003-07-23 Bespak Plc Dispensing device for a powdered product
US20090246281A1 (en) 2003-11-03 2009-10-01 Norton Healthcare Ltd. Soft steroid compositions for use in dry powder inhalers
WO2006016530A1 (ja) 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
GB0524194D0 (en) 2005-11-28 2006-01-04 Univ Aston Respirable powders
EP1960022A1 (en) 2005-11-29 2008-08-27 Alza Corporation Nasal delivery device for the delivery of a substance to the olfactory region
US20070178166A1 (en) 2005-12-15 2007-08-02 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
ES2652415T3 (es) * 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
WO2009050726A2 (en) 2007-05-28 2009-04-23 Panacea Biotec Limited Compositions and methods for improved delivery of bupropion
RU2491067C2 (ru) 2007-08-06 2013-08-27 Байотай Терапис, Инк Способы лечения зависимости
US9101539B2 (en) 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
CN102166219B (zh) * 2010-05-25 2013-04-17 杭州天龙药业有限公司 一种鼻腔给药制剂及其应用
WO2012078804A1 (en) 2010-12-07 2012-06-14 Respira Therapeutics, Inc. Dry powder inhaler
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
US9789071B2 (en) 2012-06-27 2017-10-17 G2B Pharma, Inc. Intranasal formulation of epinephrine for the treatment of anaphylaxis
WO2014134070A1 (en) 2013-02-26 2014-09-04 Baxter International Inc. Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
CN104274426A (zh) 2013-07-03 2015-01-14 陆克塞纳医药公司 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途
US20160220489A1 (en) 2013-09-03 2016-08-04 G2B Pharma Inc. Intranasal Formulation for the Treatment of Cardiopulmonary Resuscitation (CPR), Cardiac Life Support (CLS), Anaphylaxis and/or Anaphylactoid Reactions
CN105979999B (zh) 2013-12-11 2021-03-12 株式会社Jms 阳型连接器
AU2015228541B2 (en) 2014-03-14 2020-09-03 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use
US20200069582A1 (en) 2014-07-03 2020-03-05 Darren Rubin Inhalable hemodynamic agents and methods of using the same
CN107205938A (zh) * 2014-12-18 2017-09-26 温德加普医疗股份有限公司 用于溶解或增溶治疗剂的方法和组合物
UA121874C2 (uk) 2015-02-17 2020-08-10 Елі Ліллі Енд Компані Порошкова назальна композиція для лікування гіпоглікемії
EP3842457A1 (en) 2015-09-09 2021-06-30 Novartis AG Thymic stromal lymphopoietin (tslp)-binding molecules and methods of using the molecules
CA3030359A1 (en) 2016-08-05 2018-02-08 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical powder compositions
CN110996912A (zh) * 2017-08-20 2020-04-10 福摩莱克斯医药创新有限公司 用于鼻内递送的干粉组合物
US11844859B2 (en) * 2017-08-20 2023-12-19 Nasus Pharma Ltd. Dry powder compositions for intranasal delivery
ES2791775B2 (es) * 2018-02-06 2023-01-20 Aegis Therapeutics Llc Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades
KR20200125632A (ko) * 2018-02-26 2020-11-04 신 니뽄 바이오메디칼 라보라토리즈, 엘티디. 분말 제제, 카트리지 및 디바이스
US11400045B2 (en) * 2020-03-16 2022-08-02 Nasus Pharma Ltd. Treatment with powdered intranasal epinephrine

Similar Documents

Publication Publication Date Title
TWI583384B (zh) 包含4-胺基-5-氟-3-[6-(4-甲基哌嗪-1-基)-1h-苯并咪唑-2-基]-1h-喹啉-2-酮乳酸鹽單水合物之醫藥組合物
US20130095180A1 (en) Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration
JP5911969B2 (ja) 心臓血管障害の治療方法
JP2007533686A5 (cg-RX-API-DMAC7.html)
ES2240033T3 (es) Comprimido matricial que permite la liberacion prolongada de trimetazidina tras su administracion oral.
JP2005512995A5 (cg-RX-API-DMAC7.html)
PT2124556E (pt) Composições farmacêuticas
ES3056013T3 (en) Bi-layer pharmaceutical tablet formulation
JP2006527195A (ja) トリプタンおよびnsaidを含む組成物
ES2324769T3 (es) Comprimido que comprende cetrizina y pseudoefedrina.
CN1972730A (zh) 格隆溴铵用于治疗儿童哮喘
JP2005515991A (ja) 5ht1レセプターアゴニストを含む医薬組成物
WO2005094832A1 (en) Compositions comprising meloxicam
JP2012036200A (ja) 他の薬剤と組合せた(r,r)−ホルモテロール
JP2016537364A5 (cg-RX-API-DMAC7.html)
JP5713421B1 (ja) 口腔内崩壊錠
ES2241777T3 (es) Composiciones farmaceuticas que contienen terbinafina.
ES2582012T3 (es) Composiciones farmacéuticas de levetiracetam
KR20060109919A (ko) 5-ht-수용체 아고니스트류를 위한 경구 제제들, 그들의용도 및 그들을 이용한 치료 방법
JP2009535336A (ja) 片頭痛治療用の固定組合せ剤形
KR20210137484A (ko) 캡시드 조립 조절제 고체 제형
WO2008068778A2 (en) Extended release pharmaceutical composition of pramipexole
JP2513656B2 (ja) 血小板凝集阻止作用を有する併用組合せ製剤
PT1646373E (pt) Composição farmacêutica orodispersível de um composto antitrombótico
WO2023080910A1 (en) Compositions containing dofetilide and mexiletine and uses thereof